{"disease":{"id":"eculizumab","name":"eculizumab"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04079257","title":"The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria","phase":"","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04725812","title":"Complement Regulation to Undo Systemic Harm in Preeclampsia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}